Isolation and identification of Klebsiella pneumonia from wound infections and study of the synergistic effect of carpenems and cefepime
DOI:
https://doi.org/10.32792/utq/utjsci/v11i2.1221Abstract
Surgical site infection (SSI) is a major source of morbidity and mortality in developing countries despite recent advances in sterile techniques. We studied antibiotics through their effect on bacterial pathogens isolated from wound infections singly and synergistically, which were observed in hospitals in Dhi Qar Governorate. These bacteria, Klebsiella pneumoniae 300 clinical samples were collected from Al-Hussein Teaching, Nasiriya Teaching and Al-Haboubi Teaching Hospitals in Dhi Qar Governorate for the period from September - December 2023. The results showed the presence of 16 bacterial isolates belonging to K. Pneumonia. Statistical and descriptive analysis was performed using chi-square. The rates of antibiotic resistance varied through the use of 4 types of carpenems and one type of cephalosporins. The resistance rate to meropenem alone was 6 (37.5%), while the resistance rate was higher for meropenem synergistically with Imipenem, Ertapenem, Doripenem, and cefepime, 7 (43.8%), respectively. In case of synergy the resistance rate was as to Imipenem, 7 (43.8) alone, while in synergy, the resistance rate was lower for Imipenem with cefepime, Ertapenem, and Doripenem, 5 (29.4%), 5 (31.3%), 6 (37.5%), respectively the resistance rate for synergy was highest than cefepime which was 11 (68.8) alone, while synergistically the resistance rate was lower for cefepime with Ertapenem and Doripenem 7 (38.9%), 7 (43.8%) respectively. While resistance to Ertapenem was higher than Doripenem 9 (56.3) and 7 (43.8), respectively, alone and synergistically, the resistance rate was lower for Ertapenem with Doripenem 5 (31.3%). This study revealed that taking two synergistic
Received: 2024-04-05
Revised: 2024-04-22
Accepted: 2024-05-02
References
[ K . L . Wyres, M. Lam, and K. E. Holt, "Population genomics of Klebsiella pneumoniae". Nature Reviews Microbiology, 18(6), 344-359,2020.
[ R. M. Martin, and M. Bachman, "Colonization, infection, and the accessory genome of Klebsiella pneumoniae". Front. Cell Infect Microbial. 8: 4, 2018.
]3] G. Wang, G. Zhao, X. Chao, L. Xie, and H. Wang, "The characteristics of virulence, biofilm and antibiotic resistance of Klebsiella pneumoniae". International Journal of Environmental Research and Public Health, 17(17), 6278 , 2020.
]4 [ C. Y. Effah, T. Sun, S. Liu, and Y. Wu, "Klebsiella pneumoniae: an increasing threat to public health". Annals of clinical microbiology and antimicrobials, 19(1), 1-9, 2020.
] 5[ R. A. Ramadan, A. M. Bedawy, E. M. Negm, , T. H. Hassan, D. A.Ibrahim, S. M. ElSheikh , and R. M. Amer, "Carbapenem-resistant Klebsiella pneumoniae among patients with ventilator-associated pneumonia": Evaluation of antibiotic combinations and susceptibility to new antibiotics". Infection and Drug Resistance, 3537-3548, 2022.
]6[ K. Ssekatawa, D. K. Byarugaba, J. L. Nakavuma, C. D. Kato, F .Ejobi, R. Tweyongyere, and W. M. Eddie, "Prevalence of pathogenic Klebsiella pneumoniae based on PCR capsular typing harboring Carbapenemases encoding genes in Uganda tertiary hospitals". Antimicrobial Resistance & Infection Control, 10, 1-10 , 2021.
]7[P. P. Kalelkar, M. Riddick, , and A. J. Garcia, "Biomaterial-based antimicrobial therapies for the treatment of bacterial infections", Nature Reviews Materials, 7(1), 39-54, 2022.
]8[ E. Goldman, and H. G. Lorrence, Practical Handbook of Microbiology. 2nd.ed. U. S. A , 2009.
]9[I. Stock, and B. Wiedemenn, "Natural antibiotic susceptibility of Klebsiella pneumoniae, K. oxytoca, K. planticola, K. ornithinolytica and K. terrigena strains". J. Med. Microbiol. 50:396-406, 2001.
]10[C. Nithya, C. Aravindraja, and S. K. Pandian, "Bacillus pumilus of Palk Bay origin inhibits quorum-sensing-mediated virulence factors in Gram negative bacteria". Research in microbiology, 161(4), 293-304, 2010.
]11] J.M.Pages, J.P. Lavigne, V. Leflon- Guibout, E. Marcon, F.Bert, L. Noussair, and M.H. Nicolas Chanoine, "Efflux Pump, the Masked side of β-lactam resistance in Klebsiella pneumoniae clinical isolates". PLoS ONE; 4(3):177-180, 2009.
]12[ W. Levinson, and E. Jawetz, "Medical microbiology and Immunology th edition". Appleton & Lange,2000.
]13[ D. Mansury, M. Motamedifar, J Sarvari, B. Shirazi, and A. Khaledi, "Antibiotic susceptibility pattern and identification of extended spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae from Shiraz, Iran". Iran. J. Microbiology 8(1):55-61, 2016.
]14 [K. T. Shilpa, R. Rubyand, and R. Allavarapu, "Isolation and Antimicrobial sensitivity pattern of Klebsiella pneumonia from sputum samples in a tertiary care hospital". Int. J. Curr Res. Med. Sci. 2(1): 58-64, 2016.
]15[ L. Chang, I. Bastian, and M. Warner, "Survey of Klebsiella pneumonia bacteremia in two South Australian hospitals and detection of hyper mucoviscous phenotype and magA/rmpA genotypes in K. pneumoniae isolates". Diagnostic Microbiology and Infectious Dis. 41:559-563,2016.
[ Z. Hossein zadeh, H. Sedigh Ebrahim-Saraie, J.Sarvari, J.Mardaneh, B. Dehghani, and S. Rokni-Hosseini, "Emerge of blaNDM-1 and blaOXA-48-like harboring carbapenem resistant Klebsiella pneumonia isolates from hospitalized patients in southwestern Iran". J Chinese Medical Association, 81:536-540,2018.
]17 [E.M. Jarallah, and F.M. Abbas, "Prevalence of VIM Metallo ß–Lactamase among Clinical Isolates of in Hilla Hospitals". Medical J. Babylon 11(4):825-835,2014.
]18[ T. Zhou, Y .Zhang, M. Li, X. Yu, Y. Sun, and J. Xu, "An outbreak of infections caused by extensively drug-resistant Klebsiella pneumoniae strains during a short period of time in a Chinese teaching hospital: epidemiology study and molecular characteristics", Diagnostic Microbiology and Infectious Dis., 82:240-244, 2015.
Published
License
Copyright (c) 2024 University of Thi-Qar Journal of Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
